Agenus (AGEN) Director Brian Corvese Receives 100,000-Share Award

What Happened

• Brian Corvese, a director of Agenus Inc. (AGEN), received an award on August 5, 2026 for 100,000 shares reported as a derivative (grant) at $0.00 — i.e., an option/award rather than a cash purchase or sale. No cash was exchanged at grant.

Key Details

• Transaction date: 2026-08-05; Filing date (Form 4): 2026-08-11.
• Instrument: Award/Grant (derivative) for 100,000 shares, reported price $0.00.
• Vesting: Award granted under the Agenus 2019 Amended and Restated Equity Incentive Plan; vests over three years — 1/3 on the first anniversary of the grant date, then the remaining 2/3 in two equal annual installments (see footnote).
• Shares owned after transaction: Not specified in this filing.
• Timeliness: The Form 4 was filed six days after the transaction date. Form 4s are generally due within two business days of a reportable transaction, so this filing appears later than that standard window.

Context

• This was an equity award (derivative grant), not an open-market buy or sale. Such grants are common for directors and compensate service; they do not necessarily indicate immediate bullish or bearish trading by the insider.
• Because this is a grant with multi-year vesting, the economic benefit to the insider depends on future vesting and the company’s stock performance.